Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study)
<p>Introduction</p> ‘Real world’ bleeding in patients exposed to different regimens of dual antiplatelet therapy (DAPT) and triple therapy (TT, DAPT plus an anticoagulant) have a clinical and economic impact but have not been previously quantified. <p>Methods and analysis</p>...
Main Authors: | Pufulete, M, Harris, J, Sterne, J, Johnson, T, Lasserson, D, Mumford, A, Doble, B, Wordsworth, S, Benedetto, U, Rogers, C, Loke, Y, Pithara, C, Redwood, S, Reeves, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2019
|
Similar Items
-
Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study)
by: Chris A Rogers, et al.
Published: (2019-06-01) -
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
by: Harris Jessica, et al.
Published: (2023-05-01) -
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
by: Pufulete, M, et al.
Published: (2022) -
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
by: Barney C Reeves, et al.
Published: (2022-08-01) -
Patient perspectives of nuisance bleeding and adherence to dual antiplatelet therapy: a qualitative study
by: Maria Pufulete, et al.
Published: (2020-12-01)